Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Provided By GlobeNewswire
Last update: Sep 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10, 2025, at 11:00 a.m. ET.
Read more at globenewswire.com
